# Burn Wound Management of Betafoam® and Allevyn® Ag

> **NCT02660541** · NA · COMPLETED · sponsor: **Mundipharma Korea Ltd** · enrollment: 32 (actual)

## Conditions studied

- Acute Burn

## Interventions

- **DEVICE:** Betafoam
- **DEVICE:** Allevyn Silver Dressing

## Key facts

- **NCT ID:** NCT02660541
- **Lead sponsor:** Mundipharma Korea Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-21
- **Primary completion:** 2017-02-28
- **Final completion:** 2017-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02660541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02660541, "Burn Wound Management of Betafoam® and Allevyn® Ag". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02660541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*